The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc
in developing countries, 488
dietary fiber and, 458 , 480
dietary protein and, 457 , 458
dose-response assessment for ULs, 483-488
in drinking water, 483
EARs, 24-25 , 466 , 468 , 469 , 470 , 475 , 477 , 479
elderly people, 451 , 474-475 , 479 , 559 , 562
endogenous losses, 446 , 448 , 449 , 462 , 463 , 469 , 471-473 , 476
and enzyme (zinc-dependent) activity, 15 , 443 , 452-453
in erythrocytes, 442 , 451 , 452 , 453 , 473 , 482
evidence considered in setting EAR, 463-466 , 467-470 , 471-475 , 476-479
excretion, 446 , 448 , 463-464 , 471-473
exposure assessment, 487
factorial analysis, 15 , 442 , 447 , 462 , 463 , 467 , 468 , 469-470 , 471-473 , 476
factors affecting requirement, 454-458
fasting/starvation and, 446 , 448 , 451
fetal, 477
finger proteins, 443 , 444 , 454
folate and, 456
food composition data, 560
food sources, 463 , 479 , 480
fortified foods, 480 , 575
fractional absorption method, 15 , 447-448 , 449 , 450 , 462 , 463 , 468 , 469 , 472 , 473 , 474 , 476 , 478
functions, 15 , 44 , 108 , 442-444
and gastrointestinal distress, 482
gender and, 15 , 56-57 , 442 , 469 , 470 , 471-472 , 473-474 , 475 , 480-481 , 482 , 488 , 638-641 , 652-653 , 672-673 , 678-679
and gene expression, 15 , 442 , 443 , 454
gene markers of status, 453
and growth velocity, 444 , 446-447 , 449-450 , 452 , 454 , 462 , 464 , 465-466 , 467-468
in hair, 452 , 480
hazard identification, 481-483
and hepatic proteins, 454
and hormone metabolism, 443 , 444 , 454
in human milk, 6 , 51 , 457 , 460-462 , 463 , 465 , 477-478
and immune function, 443 , 444 , 447 , 449 , 453 , 474-475 , 481 , 482 , 488
indicators of adequacy, 24-25 , 447-454 , 488-489
infants, 51 , 234 , 458-466 , 486-487
and infection, 445
intakes, 57 , 442 , 463 , 466 , 467 , 480-481 , 487 , 559 , 562 , 574-575 , 638-641 , 652-653 , 672-673 , 678-679
interactions with other nutrients, 108-109 , 455-457 , 458 , 462 , 479 , 480 , 482-483 , 506
international comparisons, 476
intestinal losses, 448 , 456 , 463-464 , 472 , 476
and iron, 304 , 357-358 , 373 , 455 , 458 , 482-483
laboratory assays, 452 , 471 , 474
lactation, 477-479 , 487 , 488
by life-stage group, 24-25 , 27 , 458-480 , 483-487 , 638-641 , 652-653 , 672-673 , 678-679
and lipoproteins, 482
malabsorption syndromes, 445 , 446 , 457
and Menke’s disease, 488
menstrual losses, 446 , 448 , 469 , 471-472
metabolism, 445-446 , 474
metalloenzymes, 443
and metallothionein, 234 , 443 , 444 , 453 , 456 , 473
method used to set AI, 459 , 462
method used to set EAR, 15 , 442 , 463 , 467 , 468 , 469-470 , 476 , 572
methodological issues, 452 , 476
MTF1 binding, 443
NOAEL/LOAEL, 484-486
and 5'-nucleotidase activity, 453 , 473-474
phosphorus and, 455-456 , 457
phytic acid/phytates and, 444 , 451 , 452 , 456 , 457-458 , 479 , 480 , 572 , 576
picolinic acid and, 458
plasma concentrations, 445-446 , 447 , 450-452 , 455 , 473 , 476 , 480
pre-albumin and, 454 , 473
pregnancy, 447 , 476-477 , 487 , 488
protein-energy deficiency and, 108
radiotracer studies, 357-358 , 455 , 472 , 489
RDAs, 15 , 24-25 , 442 , 466 , 468 , 469 , 470 , 475 , 477 , 479 , 557 , 574
regulatory role, 15 , 443-444 , 454
